News

Supera Farma is a Brazilian pharmaceutical company co-owned by Cristalia and Eurofarma. Merck will own 51% of the JV, managed by a joint board and leadership team, and

The European Commission approved tafamidis (the trade name in the European Union is VYNDAQEL) in November 2011, the company said. The FDA has granted the tafamidis NDA a

The LabNexus laboratory outreach solution is easy to navigate, secure, and accessible, enabling physicians to provide premium healthcare to their patients from anywhere they have an internet connection.

The comparative study will evaluate the potential increase in survival rates, thrombin levels and in vivo recovery of Factor VIIa-CTP. The study reported that Factor VIIa-CTP showed superior

The FDA request reflects a 17% increase over the FDA enacted budget for FY 2012. The FY 2013 request covers the period from 1 October 2012 through 30

The FBP vaccine comprises E39 peptide integrated with the immune adjuvant, granulocyte macrophage-colony stimulating factor (GM-CSF). The study will examine if the FBP vaccine is safe and effective

The results from the TBS-2 Phase II Vibrotactile Stimulation (VTS) study demonstrated that Tefina had met all study endpoints. The VTS study measured the occurrence of, time to

LPT3-04 is a natural occurring dietary substance with proven safety and tolerance profile. The double-blind placebo-controlled human clinical study randomized 32 healthy, overweight and mildly obese adult volunteers

Mylan CEO Heather Bresch said they are actively addressing, shortages of the vital drug resulting from manufacturing issues that other suppliers have experienced. "Mylan has already ramped up